Matthew Deans

Matt Deans, Chief Strategy Officer and Executive Vice President-Renal Division, has been in the ancillary healthcare industry for almost twenty years covering home and specialty infusion, durable medical equipment and home health/hospice services. Matt’s experience in these sectors spans the functions of commercial, operations, business and corporate development, as well as pharmaceutical supply chain and procurement.

Prior to joining Pentec Health, Matt served as Senior Vice President of Business Development for Option Care Health. In this role he led the product and service development efforts across pharmaceutical manufacturers, health plans, healthcare systems and providers. Additionally, his responsibilities included general management over Option Care Health’s high-risk obstetrical home care and network management businesses and oversight of the trade relations and supply chain function covering $1B+ annually in pharmaceutical spend. Matt was part of the management team that led the sale and carve out of Walgreens Infusion Services to Madison Dearborn Partners in 2015 to form Option Care and completed the merger with BioScrip in 2019 to form Option Care Health.

Matt holds a BA from Augustana College in Rock Island, IL, with a Major in Business Administration and Minor in Political Science. He also holds an MBA in Health Sector Management from DePaul University in Chicago, IL.